Clinical Trial Update: Dental Implant Placement in Adjunction With Autologous Alveolar Bone-Marrow Derived Mesenchymal Stem Cells (aBM-MSCs) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial exploring dental implant placement with autologous alveolar bone-marrow derived mesenchymal stem cells, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Implant Therapy

Drugs mentioned

• autologous alveolar bone-marrow derived mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Aristotle University Of Thessaloniki | Conditions: Implant Therapy | Phase 1, Phase 2 | Status: COMPLETED